In summary, our findings provide evidence showing that mSjci could attenuate DSS-induced colitis in mice by inhibiting the production of IFN-γ, promoting the expression of IL-10 and enhancing the population of CD4+CD25+ Treg cells. Here, IL10 is linked to colitis.